Search research articles
Contact Us
Filters
Showing results (61-70 of 85) with videos related to
Page
of 9
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 27, 2005
Interleukin 1B gene (IL-1B) and interleukin 1 receptor antagonist gene (IL-1RN) polymorphisms in Helicobacter pylori-negative gastric cancer of intestinal and diffuse histotype
A Ruzzo, F Graziano, F Pizzagalli, et al.
Blood Advances
|
January 4, 2018
Bortezomib-based antibody depletion for refractory autoimmune hematological diseases
Sumita Ratnasingam, Patricia A Walker, Huy Tran, et al.
British Journal of Cancer
|
March 1, 2002
Infusional 5-fluorouracil, cisplatin and mitomycin C in advanced gastric cancer: a low cost effective regimen
S Cascinu, A M Baldelli, V Catalano, et al.
BMC Cancer
|
May 12, 2006
Weekly oxaliplatin, 5-fluorouracil and folinic acid (OXALF) as first-line chemotherapy for elderly patients with advanced gastric cancer: results of a phase II trial
D Santini, F Graziano, V Catalano, et al.
The Pharmacogenomics Journal
|
February 24, 2010
Genetic modulation of the Let-7 microRNA binding to KRAS 3'-untranslated region and survival of metastatic colorectal cancer patients treated with salvage cetuximab-irinotecan
F Graziano, E Canestrari, F Loupakis, et al.
Cancer Investigation
|
June 2, 2000
Effects of calcium and vitamin supplementation on colon cell proliferation in colorectal cancer
S Cascinu, M Ligi, E Del Ferro, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 21, 2017
SIMPLIFY-1: A Phase III Randomized Trial of Momelotinib Versus Ruxolitinib in Janus Kinase Inhibitor-Naïve Patients With Myelofibrosis
Ruben A Mesa, Jean-Jacques Kiladjian, John V Catalano, et al.
British Journal of Cancer
|
March 5, 2009
Mucinous histology predicts for poor response rate and overall survival of patients with colorectal cancer and treated with first-line oxaliplatin- and/or irinotecan-based chemotherapy
V Catalano, F Loupakis, F Graziano, et al.
British Journal of Cancer
|
August 30, 2008
Liver-only metastatic colorectal cancer patients and thymidylate synthase polymorphisms for predicting response to 5-fluorouracil-based chemotherapy
F Graziano, A Ruzzo, F Loupakis, et al.
The Pharmacogenomics Journal
|
March 2, 2016
Glycolysis gene expression analysis and selective metabolic advantage in the clinical progression of colorectal cancer
F Graziano, A Ruzzo, E Giacomini, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 85) with videos related to
Sort By:
Page
of 9
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 27, 2005
Interleukin 1B gene (IL-1B) and interleukin 1 receptor antagonist gene (IL-1RN) polymorphisms in Helicobacter pylori-negative gastric cancer of intestinal and diffuse histotype
A Ruzzo, F Graziano, F Pizzagalli, et al.
Blood Advances
|
January 4, 2018
Bortezomib-based antibody depletion for refractory autoimmune hematological diseases
Sumita Ratnasingam, Patricia A Walker, Huy Tran, et al.
British Journal of Cancer
|
March 1, 2002
Infusional 5-fluorouracil, cisplatin and mitomycin C in advanced gastric cancer: a low cost effective regimen
S Cascinu, A M Baldelli, V Catalano, et al.
BMC Cancer
|
May 12, 2006
Weekly oxaliplatin, 5-fluorouracil and folinic acid (OXALF) as first-line chemotherapy for elderly patients with advanced gastric cancer: results of a phase II trial
D Santini, F Graziano, V Catalano, et al.
The Pharmacogenomics Journal
|
February 24, 2010
Genetic modulation of the Let-7 microRNA binding to KRAS 3'-untranslated region and survival of metastatic colorectal cancer patients treated with salvage cetuximab-irinotecan
F Graziano, E Canestrari, F Loupakis, et al.
Cancer Investigation
|
June 2, 2000
Effects of calcium and vitamin supplementation on colon cell proliferation in colorectal cancer
S Cascinu, M Ligi, E Del Ferro, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 21, 2017
SIMPLIFY-1: A Phase III Randomized Trial of Momelotinib Versus Ruxolitinib in Janus Kinase Inhibitor-Naïve Patients With Myelofibrosis
Ruben A Mesa, Jean-Jacques Kiladjian, John V Catalano, et al.
British Journal of Cancer
|
March 5, 2009
Mucinous histology predicts for poor response rate and overall survival of patients with colorectal cancer and treated with first-line oxaliplatin- and/or irinotecan-based chemotherapy
V Catalano, F Loupakis, F Graziano, et al.
British Journal of Cancer
|
August 30, 2008
Liver-only metastatic colorectal cancer patients and thymidylate synthase polymorphisms for predicting response to 5-fluorouracil-based chemotherapy
F Graziano, A Ruzzo, F Loupakis, et al.
The Pharmacogenomics Journal
|
March 2, 2016
Glycolysis gene expression analysis and selective metabolic advantage in the clinical progression of colorectal cancer
F Graziano, A Ruzzo, E Giacomini, et al.
Page
of 9